Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 1475 entries
View as:

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04025879 Org: User:
Start: 11/05/19 End: 07/30/27 Due: 07/30/28

A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent

Phase: N/A Priority: Normal
NCT ID: NCT05546151 Org: User:
Start: 09/28/22 End: 04/07/23 Due: 04/07/24

Drug Interaction - Oral Contraceptive

Phase: N/A Priority: Normal
NCT ID: NCT00399685 Org: User:
Start: 12/31/06 End: 08/31/07 Due: 08/31/08

Study Assessing the Effects of Darunavir/Ritonavir or Lopinavir/Ritonavir on the Pharmacokinetics of Daclatasvir in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02159352 Org: User:
Start: 06/30/14 End: 07/31/14 Due: 07/31/15

Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)

Phase: N/A Priority: Normal
NCT ID: NCT00261365 Org: User:
Start: 11/30/05 End: 10/31/07 Due: 10/31/08

An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02488759 Org: User:
Start: 10/13/15 End: 10/24/22 Due: 10/24/23

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT00135434 Org: User:
Start: 09/30/04 End: 06/30/05 Due: 06/30/06

A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06094296 Org: User:
Start: 11/27/23 End: 08/08/24 Due: 08/08/25

Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00096746 Org: User:
Start: 11/30/04 End: 09/30/06 Due: 09/30/07

A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

Phase: N/A Priority: Normal
NCT ID: NCT05891249 Org: User:
Start: 06/05/23 End: 04/16/26 Due: 04/16/27

Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00909766 Org: User:
Start: 08/31/09 End: 06/30/11 Due: 06/30/12

Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01986218 Org: User:
Start: 11/30/13 End: 03/31/16 Due: 03/31/17

An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02538666 Org: User:
Start: 10/13/15 End: 11/11/21 Due: 11/11/22

Korean Post-marketing Surveillance for Sprycel®

Phase: N/A Priority: Normal
NCT ID: NCT01464047 Org: User:
Start: 10/31/11 End: 08/31/15 Due: 08/31/16

Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06422247 Org: User:
Start: 04/05/24 End: 02/05/25 Due: 02/05/26

A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06869551 Org: User:
Start: 03/13/25 End: 03/04/31 Due: 03/04/32

A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04956627 Org: User:
Start: 07/28/21 End: 04/27/22 Due: 04/27/23

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01335399 Org: User:
Start: 08/04/11 End: 09/03/21 Due: 09/03/22

Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01835470 Org: User:
Start: 08/09/13 End: 07/30/18 Due: 07/30/19

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Phase: N/A Priority: Normal
NCT ID: NCT07011732 Org: User:
Start: 07/18/25 End: 12/08/28 Due: 12/08/29

Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants

Phase: N/A Priority: Normal
NCT ID: NCT00113191 Org: User:
Start: 05/31/04 End: 06/30/06 Due: 06/30/07

A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)

Phase: N/A Priority: Normal
NCT ID: NCT05324436 Org: User:
Start: 01/08/22 End: 06/30/23 Due: 06/30/24

Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study

Phase: N/A Priority: Normal
NCT ID: NCT02780089 Org: User:
Start: 10/23/15 End: 09/08/20 Due: 09/08/21

A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

Phase: N/A Priority: Normal
NCT ID: NCT03668119 Org: User:
Start: 10/31/18 End: 08/02/23 Due: 08/02/24

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Phase: N/A Priority: Normal
NCT ID: NCT00326716 Org: User:
Start: 06/30/06 End: 08/31/09 Due: 08/31/10